Related Experiment Video
Updated: Aug 6, 2025
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.0K
Management of systemic sclerosis: British Society for Rheumatology guideline scope
Christopher P Denton1, Enrico De Lorenzis2, Elen Roblin3
1Centre for Rheumatology, Division of Medicine, University College London, London, UK.
Rheumatology Advances in Practice
|March 16, 2023
Summary
This guideline offers a practical roadmap for managing Systemic Sclerosis (SSc), incorporating new evidence-based treatments and addressing specific complications. It covers assessment, classification, and emerging therapies for interstitial lung disease.
Area of Science:
- Rheumatology
- Clinical Practice Guidelines
Background:
- Systemic Sclerosis (SSc) management requires updated guidelines due to treatment advances.
- Previous guidelines need enhancement with current evidence-based practices.
Purpose of the Study:
- To provide a practical roadmap for SSc management.
- To incorporate advances in evidence-based treatment, assessment, and classification.
- To address specific SSc complications and quality of life impacts.
Main Methods:
- Development follows "Creating Clinical Guidelines: Our Protocol".
- Incorporates latest evidence-based treatments and knowledge.
- Considers NHS England prescribing policies and national guidance.
Main Results:
- Guideline covers general SSc management.
- Addresses specific complications: lung, cardiac, renal, GI disease, RP, digital vasculopathy, skin, calcinosis.
- Includes guidance on emerging therapies for interstitial lung disease.
Conclusions:
- The guideline offers updated, evidence-based recommendations for SSc management.
- It provides comprehensive advice on managing SSc and its complications.
- The guideline is accredited by the National Institute for Health and Care Excellence.
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
23
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
23
01:20Rheumatic Heart Disease IV: Nursing Management
26
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
26
01:26Atherosclerosis III: Management
16
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
01:22Myocarditis IV: Nursing Management
16
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
16
01:20Myasthenia Gravis: Overview and Treatment
1.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.7K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K